KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Regeneron Pharmaceuticals (REGN) Tax Rate (2016 - 2025)

Historic Tax Rate for Regeneron Pharmaceuticals (REGN) over the last 15 years, with Q4 2025 value amounting to 19.08%.

  • Regeneron Pharmaceuticals' Tax Rate rose 148600.0% to 19.08% in Q4 2025 from the same period last year, while for Dec 2025 it was 13.88%, marking a year-over-year increase of 61900.0%. This contributed to the annual value of 13.88% for FY2025, which is 61900.0% up from last year.
  • As of Q4 2025, Regeneron Pharmaceuticals' Tax Rate stood at 19.08%, which was up 148600.0% from 17.2% recorded in Q3 2025.
  • In the past 5 years, Regeneron Pharmaceuticals' Tax Rate registered a high of 19.08% during Q4 2025, and its lowest value of 3.04% during Q1 2024.
  • Moreover, its 5-year median value for Tax Rate was 10.39% (2023), whereas its average is 9.7%.
  • As far as peak fluctuations go, Regeneron Pharmaceuticals' Tax Rate skyrocketed by 150700bps in 2021, and later plummeted by -106800bps in 2023.
  • Quarter analysis of 5 years shows Regeneron Pharmaceuticals' Tax Rate stood at 10.96% in 2021, then fell by -12bps to 9.63% in 2022, then tumbled by -111bps to 1.05% in 2023, then skyrocketed by 503bps to 4.22% in 2024, then soared by 352bps to 19.08% in 2025.
  • Its last three reported values are 19.08% in Q4 2025, 17.2% for Q3 2025, and 8.37% during Q2 2025.